TrialJournal of women's health (2002)2018

Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials.

James A Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.